Use of depot medroxyprogesterone acetate (DMPA) weakens both innate and adaptive immune responses to HIV type 1 (HIV-1) and, therefore, reduces host resistance to the infection, new data suggest. DMPA ...

本研究报道了一例41岁女性患者因长期使用醋酸甲羟孕酮(DMPA)避孕17年后出现不明原因复发性子宫积血(hematometra)的罕见病例。研究人员通过系列临床干预发现，在排除苗勒管畸形(Müllerian anomalies)等常见病因后，停用DMPA并改用依托孕烯植入剂(Implanon?)后症状完全 ...

Expert Rev of Obstet Gynecol. 2010;5(6):673-686. Each year worldwide, over 380,000 women die from pregnancy and pregnancy-related causes. If contraception were made available to unprotected women, ...

SEATTLE – April 4, 2012 – The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that ...

Depot medroxyprogesterone acetate (DMPA; Depo-Provera®, Merck & Co., Inc., NJ, USA) is a very safe and effective method of birth control that can be used by virtually every woman. However, DMPA has ...

Nearly half of women using depot medroxyprogesterone acetate, commonly known as the birth control shot, will experience high bone mineral density loss in the hip or lower spine within two years of ...

A new contraceptive option provides a possible answer to an age-old question in family planning: how to address barriers that make it difficult for women to keep using contraception consistently.

Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer to an age-old question in family planning: how to address barriers that make it ...